Technical Analysis for RZLT - Rezolute Inc.

Grade Last Price % Change Price Change
grade F 0.221 0.00% 0.0000
RZLT closed unchanged on Friday, August 23, 2019, on 5 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical RZLT trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 16.01%
Narrow Range Bar Range Contraction 16.01%

Older signals for RZLT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Rezolute, Inc., a clinical stage biopharmaceutical company, specializes in the development of drug therapies for the treatment of patients with metabolic and orphan diseases in the United States. Its products include RZ358, a human monoclonal antibody that is in Phase II clinical trial for the treatment of congenital hyperinsulinism, a devastating ultra-orphan pediatric disease; RZ402, a plasma kallikrein inhibitor, which is in late stage preclinical program for the treatment of diabetic macular edema; and RZ602, a product candidate that is in preclinical trial for the treatment of hereditary angioedema. It also develops AB101, a human recombinant insulin, which is in Phase I clinical trial for the treatment of patients with type 1 and type 2 diabetes mellitus. Rezolute, Inc. has a development and license agreement with ActiveSite Pharmaceuticals, Inc. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Louisville, Colorado.
Medicine RTT Clinical Medicine Organ Systems Monoclonal Antibodies Diabetes Mellitus Stage Biopharmaceutical Diabetic Retinopathy Drug Therapies Diabetic Macular Edema Macular Edema Hereditary Angioedema Anti–Vascular Endothelial Growth Factor Therapy Complement Deficiency Congenital Hyperinsulinism
Is RZLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.9
52 Week Low 0.09
Average Volume 19,597
200-Day Moving Average 0.2941
50-Day Moving Average 0.2303
20-Day Moving Average 0.2953
10-Day Moving Average 0.2218
Average True Range 0.064
ADX 10.34
+DI 35.7932
-DI 35.4918
Chandelier Exit (Long, 3 ATRs ) 0.304
Chandelier Exit (Short, 3 ATRs ) 0.328
Upper Bollinger Band 0.489
Lower Bollinger Band 0.1016
Percent B (%b) 0.31
BandWidth 131.188622
MACD Line -0.014
MACD Signal Line 0.0018
MACD Histogram -0.0158
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.2210
Resistance 3 (R3) 0.2210 0.2210 0.2210
Resistance 2 (R2) 0.2210 0.2210 0.2210 0.2210
Resistance 1 (R1) 0.2210 0.2210 0.2210 0.2210 0.2210
Pivot Point 0.2210 0.2210 0.2210 0.2210 0.2210
Support 1 (S1) 0.2210 0.2210 0.2210 0.2210 0.2210
Support 2 (S2) 0.2210 0.2210 0.2210 0.2210
Support 3 (S3) 0.2210 0.2210 0.2210
Support 4 (S4) 0.2210